| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |